---
layout: post
title: "Electronic Submissions; Update to the Specifications for Preparing and Submitting Postmarket Individual Case Safety Reports for Vaccines; Technical Specification"
date: 2026-02-05 19:09:10 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2021-07332
original_published: 2021-04-09 00:00:00 +0000
significance: 8.00
---

# Electronic Submissions; Update to the Specifications for Preparing and Submitting Postmarket Individual Case Safety Reports for Vaccines; Technical Specification

**Published:** February 05, 2026 19:09 UTC
**Source:** Federal Register
**Original Published:** April 09, 2021 00:00 UTC
**Document Number:** 2021-07332

## Summary

The Food and Drug Administration (FDA or Agency) Center for Biologics Evaluation and Research (CBER) is announcing the availability of version 2.2 of the Specifications for Preparing and Submitting Postmarket Individual Case Safety Reports (ICSRS) for Vaccines (Specifications). The version update is not applicable to CBER- regulated drug products marketed for human use with approved New Drug Applications (NDAs) and Abbreviated New Drug Applications (ANDAs); CBER-regulated therapeutic biological products marketed for human use with approved Biologic License Applications (BLAs); Whole Blood or blood components; and human cells, tissues, and cellular and tissue- based products (HCT/Ps) regulated solely under the Public Health Service Act.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2021/04/09/2021-07332/electronic-submissions-update-to-the-specifications-for-preparing-and-submitting-postmarket)
- API: https://www.federalregister.gov/api/v1/documents/2021-07332

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
